(Q38364577)

PubMed publication ID

2 September 2017

2 references

15 August 2020

Biosimilars advancements: Moving on to the future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

1 reference

15 August 2020

Mariana Lopes dos Santos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

Ana M Moro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

author name string

Lilian Rumi Tsuruta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

language of work or name

1 reference

23 February 2015

1 reference

PubMed publication ID

25708573

2 September 2017

16 March 2015

1 reference

15 August 2020

Biotechnology Progress

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

15 August 2020

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

page(s)

1139-1149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivatives

11 May 2020

copyright license

1 reference

15 August 2020

Human insulin from recombinant DNA technology

1 reference

Development and regulation of biosimilars: current status and future challenges.

21 January 2018

1 reference

21 January 2018

1 reference

Worldwide experience with biosimilar development

21 January 2018

1 reference

What's fueling the biotech engine-2012 to 2013.

21 January 2018

1 reference

On the regulatory approval pathway of biosimilar products

21 January 2018

1 reference

21 January 2018

1 reference

Data exclusivity for biologics.

21 January 2018

1 reference

21 January 2018

1 reference

The challenge of indication extrapolation for infliximab biosimilars

21 January 2018

1 reference

21 January 2018

1 reference

Colony stimulating factors (CSF) biosimilars. Progress?

21 January 2018

1 reference

21 January 2018

1 reference

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

21 January 2018

1 reference

21 January 2018

1 reference

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

Immunologic mechanisms of EPO-associated pure red cell aplasia

21 January 2018

1 reference

21 January 2018

1 reference

Single-use disposable technologies for biopharmaceutical manufacturing

21 January 2018

1 reference

Analytical lessons learned from selected therapeutic protein drug comparability studies

21 January 2018

1 reference

Quality of original and biosimilar epoetin products

21 January 2018

1 reference

Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies

21 January 2018

1 reference

Physicochemical characterization of Remsima

21 January 2018

1 reference

Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab

21 January 2018

1 reference

Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs

21 January 2018

1 reference

Immunogenicity of therapeutic proteins: the use of animal models

21 January 2018

1 reference

The economic pressures for biosimilar drug use in cancer medicine

21 January 2018

1 reference

Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

1 reference

International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice

21 January 2018

1 reference

12 December 2020

Biosimilars-why terminology matters

1 reference

12 December 2020

The state of the art in the development of biosimilars

1 reference

12 December 2020

Interchangeability, immunogenicity and biosimilars

1 reference

12 December 2020

The rise of the biosimilar

1 reference

12 December 2020

Fresh from the biotech pipeline--2013

1 reference

12 December 2020

Contribution of animal studies to evaluate the similarity of biosimilars to reference products.

1 reference

12 December 2020

Considerations in the early development of biosimilar products

1 reference

12 December 2020

Identifiers

DOI

10.1002/BTPR.2066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

release_s62id5fwsjgw5h5ubrzkk2pgpe

11 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s62id5fwsjgw5h5ubrzkk2pgpe

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json

11 May 2020

PubMed publication ID

25708573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6681164&resulttype=core&format=json